Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia

Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow gr...

Full description

Saved in:
Bibliographic Details
Published in:Hematology reports 2010-09, Vol.2 (1), p.e6-e6
Main Authors: Erie, Andrew J, McClure, Rebecca F, Wolanskyj, Alexandra P
Format: Article
Language:English
Subjects:
Amiodarone
Bone growth
Bone marrow
Bone Marrow Granulomas
Case-Report
Granuloma
Granulomas
Lymphoma
Pancytopenia
Sarcoidosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3
cites cdi_FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3
container_end_page e6
container_issue 1
container_start_page e6
container_title Hematology reports
container_volume 2
creator Erie, Andrew J
McClure, Rebecca F
Wolanskyj, Alexandra P
description Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient's pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug.
doi_str_mv 10.4081/hr.2010.e6
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e5da4a94125241b98f2f96888165baec</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e5da4a94125241b98f2f96888165baec</doaj_id><sourcerecordid>2438855726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3</originalsourceid><addsrcrecordid>eNpVkUFr3DAQhU1oSUKaS39AEfRWcKrRWLbcQyGENgkEeml7FWN7tOvFK20lKyH_vt5uGpK5SE96fDPDK4r3IC8qaeDzOl4ouQiuj4pTJdGUBlG-eXE_Kc5T2silsG2xkcfFiVJgKg3tafH7cjuGgWLwXI5-yD0PoluE2FKM4UGsIvk8hS2lL4K8yD6nTJPoKScWwYnI9xzT2E0sduT7xzns2I_0rnjraEp8_nSeFb--f_t5dVPe_bi-vbq8K3tEnEsE7WpXIciGFStwbQdcYasQnGscIAC0Wte1QjbUMcjaaUVdXzmA2vV4VtweuEOgjd3FcRn70QYa7b-HEFeW4jz2E1vWA1XUVqC0qqBrjVOurY0xUOuOeM_6emDtcrfloWc_R5peQV__-HFtV-HeolqqkQvg4xMghj-Z02w3IUe_7G9VhcZo3ah6cX06uPoYUorsnjuAtPtI7TrafaSW9-YPL2d6tv4PEP8CneScow</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2438855726</pqid></control><display><type>article</type><title>Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><source>EZB Electronic Journals Library</source><creator>Erie, Andrew J ; McClure, Rebecca F ; Wolanskyj, Alexandra P</creator><creatorcontrib>Erie, Andrew J ; McClure, Rebecca F ; Wolanskyj, Alexandra P</creatorcontrib><description>Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient's pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug.</description><identifier>ISSN: 2038-8330</identifier><identifier>ISSN: 2038-8322</identifier><identifier>EISSN: 2038-8330</identifier><identifier>DOI: 10.4081/hr.2010.e6</identifier><identifier>PMID: 22184519</identifier><language>eng</language><publisher>Italy: MDPI AG</publisher><subject>Amiodarone ; Bone growth ; Bone marrow ; Bone Marrow Granulomas ; Case-Report ; Granuloma ; Granulomas ; Lymphoma ; Pancytopenia ; Sarcoidosis</subject><ispartof>Hematology reports, 2010-09, Vol.2 (1), p.e6-e6</ispartof><rights>2010. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright A.J. Erie et al., 2010 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3</citedby><cites>FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222270/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2438855726?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22184519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erie, Andrew J</creatorcontrib><creatorcontrib>McClure, Rebecca F</creatorcontrib><creatorcontrib>Wolanskyj, Alexandra P</creatorcontrib><title>Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia</title><title>Hematology reports</title><addtitle>Hematol Rep</addtitle><description>Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient's pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug.</description><subject>Amiodarone</subject><subject>Bone growth</subject><subject>Bone marrow</subject><subject>Bone Marrow Granulomas</subject><subject>Case-Report</subject><subject>Granuloma</subject><subject>Granulomas</subject><subject>Lymphoma</subject><subject>Pancytopenia</subject><subject>Sarcoidosis</subject><issn>2038-8330</issn><issn>2038-8322</issn><issn>2038-8330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVkUFr3DAQhU1oSUKaS39AEfRWcKrRWLbcQyGENgkEeml7FWN7tOvFK20lKyH_vt5uGpK5SE96fDPDK4r3IC8qaeDzOl4ouQiuj4pTJdGUBlG-eXE_Kc5T2silsG2xkcfFiVJgKg3tafH7cjuGgWLwXI5-yD0PoluE2FKM4UGsIvk8hS2lL4K8yD6nTJPoKScWwYnI9xzT2E0sduT7xzns2I_0rnjraEp8_nSeFb--f_t5dVPe_bi-vbq8K3tEnEsE7WpXIciGFStwbQdcYasQnGscIAC0Wte1QjbUMcjaaUVdXzmA2vV4VtweuEOgjd3FcRn70QYa7b-HEFeW4jz2E1vWA1XUVqC0qqBrjVOurY0xUOuOeM_6emDtcrfloWc_R5peQV__-HFtV-HeolqqkQvg4xMghj-Z02w3IUe_7G9VhcZo3ah6cX06uPoYUorsnjuAtPtI7TrafaSW9-YPL2d6tv4PEP8CneScow</recordid><startdate>20100924</startdate><enddate>20100924</enddate><creator>Erie, Andrew J</creator><creator>McClure, Rebecca F</creator><creator>Wolanskyj, Alexandra P</creator><general>MDPI AG</general><general>PAGEPress Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20100924</creationdate><title>Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia</title><author>Erie, Andrew J ; McClure, Rebecca F ; Wolanskyj, Alexandra P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amiodarone</topic><topic>Bone growth</topic><topic>Bone marrow</topic><topic>Bone Marrow Granulomas</topic><topic>Case-Report</topic><topic>Granuloma</topic><topic>Granulomas</topic><topic>Lymphoma</topic><topic>Pancytopenia</topic><topic>Sarcoidosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erie, Andrew J</creatorcontrib><creatorcontrib>McClure, Rebecca F</creatorcontrib><creatorcontrib>Wolanskyj, Alexandra P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ, Directory of Open Access Journals</collection><jtitle>Hematology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erie, Andrew J</au><au>McClure, Rebecca F</au><au>Wolanskyj, Alexandra P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia</atitle><jtitle>Hematology reports</jtitle><addtitle>Hematol Rep</addtitle><date>2010-09-24</date><risdate>2010</risdate><volume>2</volume><issue>1</issue><spage>e6</spage><epage>e6</epage><pages>e6-e6</pages><issn>2038-8330</issn><issn>2038-8322</issn><eissn>2038-8330</eissn><abstract>Bone marrow infiltration by granulomas rarely presents with cytopenias and is usually a result of atypical infections, lymphomas, or sarcoidosis. Drugs are also an important but often overlooked causal agent of bone marrow granulomas. Although rare, amiodarone has been associated with bone marrow granuloma formation. This case report describes a 73-year-old male who presented with pancytopenia during a preoperative evaluation. Amiodarone therapy was suspected to be the causal agent after diagnostic evaluation and exclusion of other causes. After cessation of amiodarone, the patient's pancytopenia gradually resolved over a period of several months. Our report illustrates an often overlooked yet important cause of reversible pancytopenia owing to suspected amiodarone-induced bone marrow granuloma formation, and guides clinicians in an expected timeline for blood count improvement after cessation of this drug.</abstract><cop>Italy</cop><pub>MDPI AG</pub><pmid>22184519</pmid><doi>10.4081/hr.2010.e6</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2038-8330
ispartof Hematology reports, 2010-09, Vol.2 (1), p.e6-e6
issn 2038-8330
2038-8322
2038-8330
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e5da4a94125241b98f2f96888165baec
source PubMed Central (Open Access); Publicly Available Content Database; EZB Electronic Journals Library
subjects Amiodarone
Bone growth
Bone marrow
Bone Marrow Granulomas
Case-Report
Granuloma
Granulomas
Lymphoma
Pancytopenia
Sarcoidosis
title Amiodarone-induced bone marrow granulomas: an unusual cause of reversible pancytopenia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amiodarone-induced%20bone%20marrow%20granulomas:%20an%20unusual%20cause%20of%20reversible%20pancytopenia&rft.jtitle=Hematology%20reports&rft.au=Erie,%20Andrew%20J&rft.date=2010-09-24&rft.volume=2&rft.issue=1&rft.spage=e6&rft.epage=e6&rft.pages=e6-e6&rft.issn=2038-8330&rft.eissn=2038-8330&rft_id=info:doi/10.4081/hr.2010.e6&rft_dat=%3Cproquest_doaj_%3E2438855726%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c333t-315f6f43107e2e21f9b1e439231ff7f131119556623e8abe106f52abc4f116fc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2438855726&rft_id=info:pmid/22184519&rfr_iscdi=true